Explore Business Standard
Book Building - SME
₹ -
₹ -
-
₹ -
BSE - SME
-
-
-
Initial public offer of upto 27,36,000 equity shares of face value of Rs. 10/- each (the equity shares) of Rednex Pharmaceuticals Limited (the company or RPL or the issuer) at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs.[*] crores (public issue) out of which [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs.[*] per equity share for cash, aggregating upto Rs.[*] crores is herein after referred to as the net issue. The public issue and net issue will constitute 26.34% and [*]% respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Repayment in full or in part, of certain of the outstanding borrowings. Funding capital expenditure towards purchase of new machinery. Funding to meet Working Capital requirements. General corporate purposes.
Rednex Pharmaceuticals Ltd, Office No S6-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - info@rednexpharma.com
Website - https:, rednexpharma.com